APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C5a Anaphylatoxin Chemotactic Receptor 1

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Outlook and Growth Opportunities 2026

Report ID 173973560426 December 2025196 pages

Choose your research edition.

Industry ResearchC5a Anaphylatoxin Chemotactic Receptor 1 Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global C5a Anaphylatoxin Chemotactic Receptor 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the C5a Anaphylatoxin Chemotactic Receptor 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the C5a Anaphylatoxin Chemotactic Receptor 1 market include AFFiRiS AG, ChemoCentryx, Inc., Dompe Farmaceutici S.p.A. and Noxxon Pharma AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global C5a Anaphylatoxin Chemotactic Receptor 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C5a Anaphylatoxin Chemotactic Receptor 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C5a Anaphylatoxin Chemotactic Receptor 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the C5a Anaphylatoxin Chemotactic Receptor 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Company

AFFiRiS AG

ChemoCentryx, Inc.

Dompe Farmaceutici S.p.A.

Noxxon Pharma AG

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Type

NOXD-20

NOXD-19

EP-67

DF-2593A

Others

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Application

Allergic Asthma

Huntington Disease

Acute Pain

Kidney Disease

Others

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global C5a Anaphylatoxin Chemotactic Receptor 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions C5a Anaphylatoxin Chemotactic Receptor 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify C5a Anaphylatoxin Chemotactic Receptor 1 significant trends, drivers, influence factors in global and regions.

6. To analyze C5a Anaphylatoxin Chemotactic Receptor 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C5a Anaphylatoxin Chemotactic Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C5a Anaphylatoxin Chemotactic Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C5a Anaphylatoxin Chemotactic Receptor 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the C5a Anaphylatoxin Chemotactic Receptor 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C5a Anaphylatoxin Chemotactic Receptor 1 industry.

Chapter 3: Detailed analysis of C5a Anaphylatoxin Chemotactic Receptor 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of C5a Anaphylatoxin Chemotactic Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of C5a Anaphylatoxin Chemotactic Receptor 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Trends Table 2. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Drivers Table 3. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Opportunities and Challenges Table 4. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Restraints Table 5. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Company (2021-2026) Table 7. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Company (W Units) & (2021-2026) Table 8. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Company (2021-2026) Table 9. Global C5a Anaphylatoxin Chemotactic Receptor 1 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global C5a Anaphylatoxin Chemotactic Receptor 1 Key Company Manufacturing Base & Headquarters Table 12. Global C5a Anaphylatoxin Chemotactic Receptor 1 Company, Product Type & Application Table 13. Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global C5a Anaphylatoxin Chemotactic Receptor 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of NOXD-20 Table 18. Significant Companies of NOXD-19 Table 19. Significant Companies of EP-67 Table 20. Significant Companies of DF-2593A Table 21. Significant Companies of Others Table 22. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Type (2021-2026) & (W Units) Table 24. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Type (2027-2032) & (W Units) Table 25. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Type (2021-2026) Table 26. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Type (2027-2032) Table 27. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type (2021-2026) Table 31. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Allergic Asthma Table 33. Significant Companies of Huntington Disease Table 34. Significant Companies of Acute Pain Table 35. Significant Companies of Kidney Disease Table 36. Significant Companies of Others Table 37. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Application (2021-2026) & (W Units) Table 39. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Application (2027-2032) & (W Units) Table 40. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Application (2021-2026) Table 41. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Application (2027-2032) Table 42. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application (2021-2026) Table 46. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application (2027-2032) Table 47. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region (2021-2026) & (W Units) Table 49. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Region (2021-2026) Table 50. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region (2027-2032) & (W Units) Table 51. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Region (2027-2032) Table 52. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Region (2021-2026) Table 55. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Region (2027-2032) Table 57. Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026) & (W Units) Table 62. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Country (2021-2026) Table 63. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2027-2032) & (W Units) Table 64. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Country (2027-2032) Table 65. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Market Share by Country (2021-2026) Table 67. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Market Share by Country (2027-2032) Table 69. AFFiRiS AG Company Information Table 70. AFFiRiS AG Business Overview Table 71. AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 73. AFFiRiS AG Recent Development Table 74. ChemoCentryx, Inc. Company Information Table 75. ChemoCentryx, Inc. Business Overview Table 76. ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 78. ChemoCentryx, Inc. Recent Development Table 79. Dompe Farmaceutici S.p.A. Company Information Table 80. Dompe Farmaceutici S.p.A. Business Overview Table 81. Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 83. Dompe Farmaceutici S.p.A. Recent Development Table 84. Noxxon Pharma AG Company Information Table 85. Noxxon Pharma AG Business Overview Table 86. Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 88. Noxxon Pharma AG Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. C5a Anaphylatoxin Chemotactic Receptor 1 Distributors List Table 92. C5a Anaphylatoxin Chemotactic Receptor 1 Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. C5a Anaphylatoxin Chemotactic Receptor 1 Product Image Figure 2. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales (2021-2032) & (W Units) Figure 5. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. NOXD-20 Image Figure 10. NOXD-19 Image Figure 11. EP-67 Image Figure 12. DF-2593A Image Figure 13. Others Image Figure 14. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Type (2021-2032) Figure 17. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type (2021-2032) Figure 20. Allergic Asthma Image Figure 21. Huntington Disease Image Figure 22. Acute Pain Image Figure 23. Kidney Disease Image Figure 24. Others Image Figure 25. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Application (2021-2032) Figure 28. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application (2021-2032) Figure 31. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 32. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 36. North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 38. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 42. South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. C5a Anaphylatoxin Chemotactic Receptor 1 Value Chain Figure 130. Manufacturing Cost Structure Figure 131. C5a Anaphylatoxin Chemotactic Receptor 1 Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • NOXD-20
  • NOXD-19
  • EP-67
  • DF-2593A
  • Others
Applications
  • Allergic Asthma
  • Huntington Disease
  • Acute Pain
  • Kidney Disease
  • Others
Companies covered
  • AFFiRiS AG
  • ChemoCentryx, Inc.
  • Dompe Farmaceutici S.p.A.
  • Noxxon Pharma AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032)
  4. 1.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume (2021-2032)
  5. 1.2.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 C5a Anaphylatoxin Chemotactic Receptor 1 Market Dynamics
  1. 2.1 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Trends
  2. 2.2 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Drivers
  3. 2.3 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Opportunities and Challenges
  4. 2.4 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Restraints
3 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Company
  1. 3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Revenue Ranking in 2025
  2. 3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Company (2021-2026)
  3. 3.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Average Price by Company (2021-2026)
  5. 3.5 Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Ranking (2024-2026)
  6. 3.6 Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Product Type and Application
  8. 3.8 Global C5a Anaphylatoxin Chemotactic Receptor 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 C5a Anaphylatoxin Chemotactic Receptor 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Type
  1. 4.1 C5a Anaphylatoxin Chemotactic Receptor 1 Type Introduction
  2. 4.1.1 NOXD-20
  3. 4.1.2 NOXD-19
  4. 4.1.3 EP-67
  5. 4.1.4 DF-2593A
  6. 4.1.5 Others
  7. 4.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Type
  8. 4.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Type
  12. 4.3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Type (2021-2032)
  14. 4.3.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type (2021-2032)
5 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Application
  1. 5.1 C5a Anaphylatoxin Chemotactic Receptor 1 Application Introduction
  2. 5.1.1 Allergic Asthma
  3. 5.1.2 Huntington Disease
  4. 5.1.3 Acute Pain
  5. 5.1.4 Kidney Disease
  6. 5.1.5 Others
  7. 5.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Application
  8. 5.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume by Application (2021-2032)
  10. 5.2.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Volume Share by Application (2021-2032)
  11. 5.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Application
  12. 5.3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Application (2021-2032)
  14. 5.3.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application (2021-2032)
6 C5a Anaphylatoxin Chemotactic Receptor 1 Regional Sales and Value Analysis
  1. 6.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region (2021-2032)
  3. 6.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region: 2021-2026
  4. 6.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region (2027-2032)
  5. 6.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Region (2027-2032)
  9. 6.5 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032)
  12. 6.6.2 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032)
  15. 6.7.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032)
  21. 6.9.2 South America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Country, 2025 VS 2032
7 C5a Anaphylatoxin Chemotactic Receptor 1 Country-level Sales and Value Analysis
  1. 7.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2032)
  4. 7.3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026)
  5. 7.3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2027-2032)
  6. 7.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt C5a Anaphylatoxin Chemotactic Receptor 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AFFiRiS AG
  2. 8.1.1 AFFiRiS AG Company Information
  3. 8.1.2 AFFiRiS AG Business Overview
  4. 8.1.3 AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  6. 8.1.5 AFFiRiS AG Recent Developments
  7. 8.2 ChemoCentryx, Inc.
  8. 8.2.1 ChemoCentryx, Inc. Company Information
  9. 8.2.2 ChemoCentryx, Inc. Business Overview
  10. 8.2.3 ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  12. 8.2.5 ChemoCentryx, Inc. Recent Developments
  13. 8.3 Dompe Farmaceutici S.p.A.
  14. 8.3.1 Dompe Farmaceutici S.p.A. Company Information
  15. 8.3.2 Dompe Farmaceutici S.p.A. Business Overview
  16. 8.3.3 Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  18. 8.3.5 Dompe Farmaceutici S.p.A. Recent Developments
  19. 8.4 Noxxon Pharma AG
  20. 8.4.1 Noxxon Pharma AG Company Information
  21. 8.4.2 Noxxon Pharma AG Business Overview
  22. 8.4.3 Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  24. 8.4.5 Noxxon Pharma AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 C5a Anaphylatoxin Chemotactic Receptor 1 Value Chain Analysis
  2. 9.1.1 C5a Anaphylatoxin Chemotactic Receptor 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 C5a Anaphylatoxin Chemotactic Receptor 1 Sales Mode & Process
  6. 9.2 C5a Anaphylatoxin Chemotactic Receptor 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 C5a Anaphylatoxin Chemotactic Receptor 1 Distributors
  9. 9.2.3 C5a Anaphylatoxin Chemotactic Receptor 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst